卫生部部长陈竺
中国网3月8日讯 今日15:30,十一届全国人大三次会议将在人民大会堂三楼金色大厅举行记者会,由住房和城乡建设部部长姜伟新、卫生部部长陈竺、人力资源和社会保障部副部长胡晓义就保障和改善民生问题答记者问。
谈到关于中国是否向外国公司开放医疗市场时,卫生部部长陈竺表示,中国生物制药产业开放度是非常之高的,除了对发达国家的跨国公司的开放,也包括对发展中国家的企业的开放。
陈竺表示,当然,我们非常欢迎印度同行能够到中国来创业。因为我知道,印度的药物产业,包括非专利药物和创新药物方面,应该说在发展中国家都是处于前列的。
陈竺说,中国的医药卫生产业的市场是非常巨大的,13亿的人群,需求也是多样化的。中国政府去年启动的深化医药卫生体制改革当中,我们的重要工作之一就是建立国家基本药物制度。当然,基本药物在中国这样一个国情下,绝大多数都是预防和治疗疾病必须的,疗效非常确切和安全的,同时,又是性价比比较好的药。应该说,我们现在采取的网上统一招标采购,是欢迎各种企业来参与竞争的。我相信,有竞争力的印度企业应该有所作为。
??????????????? ??????
Translation
Minister of Health Chen Zhu
China Net March 8 hearing today, 15:30, the Third Session of the Eleventh National People's Congress in the Great Hall of the Golden Hall on the third floor press conference by the Minister of Housing and Urban-Rural Construction Jiang Weixin, Minister of Health Chen Zhu, human resources and social Hu Xiaoyi, vice minister of security protection and improving people's livelihood on the Answer Questions.
Turning to whether or not to foreign companies on China's opening up the medical market, the Minister of Health Chen Zhu said the Chinese bio-pharmaceutical industry is a very high degree of openness, in addition to the opening of the multinational corporations in developed countries, but also enterprises in developing countries open.
Chen Zhu said that, of course, we very much welcome the Indian counterparts to come to China venture. Because I know that India's pharmaceutical industry, including generic drugs and innovative drugs, it should be said that in developing countries are at the forefront.
Chen Zhu said that China's medical and health industry's market is huge, 1.3 billion people, demand is also diversified. The Chinese government launched last year, the deepening of medical and health system reform among one of our important is the establishment of national essential drug system. Of course, the essential medicines in China, such a situation, the overwhelming majority of the necessary prevention and treatment of disease, efficacy and safety of very precise, while also a good cost-effective medicine.
It should be said, we are now taking a unified online bidding and purchasing, would have welcomed a variety of businesses to participate in competition. I am confident that the competitiveness of Indian enterprises should make a difference.